June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib
Apr 17, 2025, 06:24

Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib

Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, posted on X:

PALMARES-2 real world data shows Abemaciclib>Ribociclib>Palbociclib.

This data will definitely help in choosing between the CDK4/6i.”

“Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR+/HER2- BC patients: results from the multicenter PALMARES-2 study.”

Authors: L. Provenzano, M.V. Dieci, G. Curigliano, M. Giuliano, A. Botticelli, M. Lambertini, G. Rizzo, R. Pedersini, M. Sirico, N. La Verde, A. Gennari, A. Zambelli, A. Toss, M. Piras, M. Giordano, B. Tagliaferri, D. Generali, D. Sartori, D. Miliziano, A. Menichetti, F. Ligorio, C. Zurlo, G. Griguolo, P.P. Berton Giachetti, V. Faso, C. Corti, E. Chiappe, S. Scagnoli, S. Pisegna, C. Capasso, C. De Angelis, G. Arpino, C. Criscitiello, V. Guarneri, G. Pruneri, L. Mariani, C. Vernieri

Goutham Sunny: Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib